Adverse events342

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 342

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anaemia	Blood and lymphatic system disorders	Selpercatinib - Treatment A (TRT A)	11	193	12
other	Anaemia	Blood and lymphatic system disorders	Cabozantinib or Vandetanib - Treatment B (TRT B)	10	97	16
other	Leukopenia	Blood and lymphatic system disorders	Selpercatinib - Treatment A (TRT A)	10	193	13
other	Leukopenia	Blood and lymphatic system disorders	Cabozantinib or Vandetanib - Treatment B (TRT B)	6	97	7
other	Lymphopenia	Blood and lymphatic system disorders	Selpercatinib - Treatment A (TRT A)	10	193	16
other	Lymphopenia	Blood and lymphatic system disorders	Cabozantinib or Vandetanib - Treatment B (TRT B)	4	97	4
other	Neutropenia	Blood and lymphatic system disorders	Selpercatinib - Treatment A (TRT A)	3	193	6
other	Neutropenia	Blood and lymphatic system disorders	Cabozantinib or Vandetanib - Treatment B (TRT B)	8	97	17
other	Thrombocytopenia	Blood and lymphatic system disorders	Selpercatinib - Treatment A (TRT A)	4	193	5
other	Thrombocytopenia	Blood and lymphatic system disorders	Cabozantinib or Vandetanib - Treatment B (TRT B)	9	97	10
other	Hypothyroidism	Endocrine disorders	Selpercatinib - Treatment A (TRT A)	12	193	18
other	Hypothyroidism	Endocrine disorders	Cabozantinib or Vandetanib - Treatment B (TRT B)	4	97	4
other	Abdominal distension	Gastrointestinal disorders	Selpercatinib - Treatment A (TRT A)	10	193	16
other	Abdominal distension	Gastrointestinal disorders	Cabozantinib or Vandetanib - Treatment B (TRT B)	2	97	2
other	Abdominal pain	Gastrointestinal disorders	Selpercatinib - Treatment A (TRT A)	19	193	28
other	Abdominal pain	Gastrointestinal disorders	Cabozantinib or Vandetanib - Treatment B (TRT B)	14	97	30
other	Abdominal pain upper	Gastrointestinal disorders	Selpercatinib - Treatment A (TRT A)	16	193	19
other	Abdominal pain upper	Gastrointestinal disorders	Cabozantinib or Vandetanib - Treatment B (TRT B)	7	97	12
other	Ascites	Gastrointestinal disorders	Selpercatinib - Treatment A (TRT A)	11	193	11
other	Ascites	Gastrointestinal disorders	Cabozantinib or Vandetanib - Treatment B (TRT B)	0	97	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04211337/events

API reference For AI assistants

Adverse events342

Sources 3

Read this list from software.